Search research articles
Contact Us
Filters
Showing results (31-40 of 94) with videos related to
Page
of 10
Sort By:
Gastroenterology Clinics of North America
|
December 20, 2002
Immunoprevention of colorectal cancer: a future possibility?
Pier-Luigi Lollini, Carla De Giovanni, Giordano Nicoletti, et al.
Oncotarget
|
February 2, 2015
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
Irma Airoldi, Maria Grazia Tupone, Silvia Esposito, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2021
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome
Carlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2003
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice
Anna Maria Orengo, Emma Di Carlo, Alberto Comes, et al.
Frontiers in Cell and Developmental Biology
|
July 1, 2021
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs
Stefania Livia Ciummo, Luigi D'Antonio, Carlo Sorrentino, et al.
European Journal of Immunology
|
July 13, 2002
IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice
Alberto Comes, Emma Di Carlo, Piero Musiani, et al.
International Immunopharmacology
|
July 16, 2003
Immunization in tumor prevention
Guido Forni, Claudia Curcio, Michela Spadaro, et al.
Journal for Immunotherapy of Cancer
|
August 2, 2019
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival
Carlo Sorrentino, Zhinan Yin, Stefania Ciummo, et al.
The Journal of Pathology
|
December 9, 2004
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway
Emma Di Carlo, Paola Cappello, Carlo Sorrentino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 14, 2013
Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma
Emma Di Carlo, Paola Bocca, Laura Emionite, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 94) with videos related to
Sort By:
Page
of 10
Gastroenterology Clinics of North America
|
December 20, 2002
Immunoprevention of colorectal cancer: a future possibility?
Pier-Luigi Lollini, Carla De Giovanni, Giordano Nicoletti, et al.
Oncotarget
|
February 2, 2015
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
Irma Airoldi, Maria Grazia Tupone, Silvia Esposito, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2021
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome
Carlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2003
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice
Anna Maria Orengo, Emma Di Carlo, Alberto Comes, et al.
Frontiers in Cell and Developmental Biology
|
July 1, 2021
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs
Stefania Livia Ciummo, Luigi D'Antonio, Carlo Sorrentino, et al.
European Journal of Immunology
|
July 13, 2002
IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice
Alberto Comes, Emma Di Carlo, Piero Musiani, et al.
International Immunopharmacology
|
July 16, 2003
Immunization in tumor prevention
Guido Forni, Claudia Curcio, Michela Spadaro, et al.
Journal for Immunotherapy of Cancer
|
August 2, 2019
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival
Carlo Sorrentino, Zhinan Yin, Stefania Ciummo, et al.
The Journal of Pathology
|
December 9, 2004
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway
Emma Di Carlo, Paola Cappello, Carlo Sorrentino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 14, 2013
Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma
Emma Di Carlo, Paola Bocca, Laura Emionite, et al.
Page
of 10